Unknown

Dataset Information

0

Bortezomib reduces neointimal hyperplasia in a rat carotid artery injury model.


ABSTRACT: BACKGROUND AND OBJECTIVES: The ubiquitin-proteasome system is the major intracellular protein degradation pathway in the eukaryotic cells. Bortezomib inhibits 26S proteasome-induced I-?B? degradation and suppresses nuclear factor-kappa B (NF-?B) activation. We examined the effect of bortezomib on neointima formation after of a rat carotid artery balloon injury. MATERIALS AND METHODS: After carotid artery balloon denudation, bortezomib was immediately administered by tail vein injection (systemic treatment) and by using an F-127 pluronic gel (perivascular treatment). Two weeks after the injury, we compared the degree of neointima formation in the carotid artery and the tissue expression patterns of NF-?B and I-?B?. RESULTS: The systemic treatment group exhibited a 29% reduction in neointima volume at two weeks after the balloon injury. On the western blot analysis, the bortezomib group exhibited an increased I-?B? expression, which suggested the inhibition of I-?B? degradation. On immunofluorescence analysis, the nuclear import of NF-?B was clearly decreased in the systemic bortezomib group. The perivascular bortezomib treatment group exhibited a significant reduction in the neointimal area (0.21±0.06 mm(2) vs. 0.06±0.01 mm(2), p<0.05), the neointima/media area ratio (1.43±0.72 vs. 0.47±0.16, p<0.05) and the % area stenosis (45.5±0.72% vs. 14.5±0.05%, p<0.05) compared with the control group. In situ vascular smooth muscle cell proliferation at 2 days after the injury was significantly inhibited (24.7±10.9% vs. 10.7±4.7%, p<0.05). CONCLUSION: Bortezomib suppressed NF-?B activation through the inhibition of I-?B? degradation, and significantly reduced neointima formation in a rat carotid artery injury model. These data suggested that bortezomib represented a new potent therapeutic agent for the prevention of restenosis.

SUBMITTER: Kim KS 

PROVIDER: S-EPMC3808854 | biostudies-other | 2013 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

Bortezomib reduces neointimal hyperplasia in a rat carotid artery injury model.

Kim Ki-Seok KS   Kim Song Yi SY   Choi Joon Hyeok JH   Joo Seung Jae SJ   Kim Dong Woon DW   Cho Myeong Chan MC  

Korean circulation journal 20130930 9


<h4>Background and objectives</h4>The ubiquitin-proteasome system is the major intracellular protein degradation pathway in the eukaryotic cells. Bortezomib inhibits 26S proteasome-induced I-κBα degradation and suppresses nuclear factor-kappa B (NF-κB) activation. We examined the effect of bortezomib on neointima formation after of a rat carotid artery balloon injury.<h4>Materials and methods</h4>After carotid artery balloon denudation, bortezomib was immediately administered by tail vein inject  ...[more]

Similar Datasets

| S-EPMC6700999 | biostudies-literature
| S-EPMC4018422 | biostudies-literature
| S-EPMC3906191 | biostudies-literature
| S-EPMC8084648 | biostudies-literature
| S-EPMC8760779 | biostudies-literature
2013-04-23 | GSE45433 | GEO
2013-04-23 | E-GEOD-45433 | biostudies-arrayexpress
| S-EPMC7860581 | biostudies-literature
| S-EPMC5040608 | biostudies-other
| S-EPMC8697976 | biostudies-literature